文/西风 7月21日，主营人用疫苗的研发、生产与销售的成都康华生物制品股份有限公司（300841）公告公司控制权拟发生变更的提示。公告称：7 月 18 日，公司收到控股 股东、实际控制人王振滔先生及其一致行动人奥康集团有限公司、持股 5%以上股东济南康悦齐明投资合伙企业（有限合伙）与上海万可欣生物科技合伙企业（有 限合伙）签订的《股份转让协议》，及王振滔与万可欣生物签订的《表决权委托协议》。根据《股份转让协议》，王振滔、奥康集团、康悦齐明拟合计向万可欣 生物转让所持有的公司 2,846.6638 万股股份，占剔除公司回购账户股份后总股本的21.9064%。根据《表决权委托协议》，王振滔在本次股份转让后，将转让后持 有的公司1,050.3517 万股股份（占剔除公司回购账户股份后总股本的 8.0829%）的表决权委托给万可欣生物行使。本次股份转让及表决权委托完成后，万可欣生物 拥有表决权的比例为29.9893%，公司控股股东将由王振滔变更为万可欣生物，公司实际控制人将由王振滔变更为无实际控制人。 一、新控股股东成立才10天，无实际控制人 新控股股东上海万可欣成立于2025年7月8日，离公司收到控股股东、实控人前 ...

Summary of Key Points Core Viewpoint - The Beijing Stock Exchange (BSE) has seen significant trading activity and new listings, indicating a growing market with increased investor interest and participation. Trading Activity - As of May 18, 2025, there are 266 companies listed on the BSE with a total share capital of 36.498 billion shares and a circulating share capital of 23.096 billion shares [2] - For the week of May 12 to May 18, the trading volume reached 8.072 billion shares, a week-on-week increase of 42.28%, while the trading amount was 173.488 billion yuan, up 39.35% from the previous week [3] - The average trading price during this period was 21.49 yuan, reflecting a decrease of 2.06% [3] - The BSE 50 Index rose by 3.13% to 1422.43 points, with 25 stocks increasing, none remaining flat, and 25 declining [3] New Listings - One company successfully listed on the BSE during the week, bringing the total to 266 [6] - Tian Gong Co., Ltd. (stock code: 920068) was the latest addition, listed on May 13, 2025, and is the first company to split from a Hong Kong stock to list on the BSE [7] - On its first trading day, Tian Gong's stock peaked with a 498.98% increase, closing at 20.17 yuan, a rise of 411.93% with a trading volume of 1.076 billion yuan [7] - As of May 19, 2025, Tian Gong's stock price reached 22.99 yuan, with a total market capitalization of 14.9 billion yuan, reflecting a 4.45% increase from its listing day [7] Upcoming Listings and Applications - As of May 18, 2024, there are 62 companies awaiting approval for listing on the BSE, including 5 under review, 48 in inquiry, and 8 submitted for registration [5] - One company, Youli Intelligent Equipment Co., Ltd. (stock code: 874325), passed the listing committee meeting during this period [12] - Youli Intelligent plans to raise 358 million yuan for the construction of a production base for photovoltaic support components and other projects [13] Financial Performance of Listed Companies - Tian Gong's revenue for 2022 to 2024 was 383 million yuan, 1.035 billion yuan, and 801 million yuan, with net profits of 70.31 million yuan, 175 million yuan, and 174 million yuan respectively [9] - For the first quarter of 2025, Tian Gong expects to achieve revenue of 192 million yuan [10] - Youli Intelligent's revenue for the same period was 433 million yuan, 658 million yuan, and 729 million yuan, with net profits of 42.19 million yuan, 78.17 million yuan, and 90.05 million yuan [14] Other Companies in the Pipeline - Several companies, including Yuelong Technology, Kelairedi, and Kanghua Co., have passed the counseling acceptance process, indicating their readiness for potential listing [20][21][24] - These companies are involved in various sectors, including medical devices, chemical pharmaceuticals, and tourism services, showcasing the diversity of industries represented on the BSE [24][26][27]